Literature DB >> 39267

Oxygen consumption during maintenance hemodialysis.

A Blumberg, G Keller.   

Abstract

The influence of hemodialysis on oxygen consumption was studied in 15 patients on maintenance dialysis. Red cell 2,3-DPG, P50, an inverse measure of oxygen affinity of hemoglobin, arterial and central venous blood gases and cardiac index were measured. 2,3-DPG remained unchanged, whereas in vivo P50 fell significantly during dialysis due to a rise of pH (Bohr effect). Arterial PO2 was lower after than before dialysis, but arterial and central venous oxygen saturations did not change significantly. Cardiac index increased from 3.66 to 4.0k liter/min/m2. Oxygen consumption rose from 120.5 to 131.7 ml/min/m2 (p less than 0.05), the rise being accounted for by an increase in cardiac index and by a slight post-dialysis hemoconcentration. However, even correcting for these parameters did not reveal a decrease in oxygen consumption. It is concluded that, contrary to previous assumptions, the hemodialysis-induced rise in pH with its consequent increase of oxygen hemoglobin affinity did not impair oxygen delivery in this group of patients on maintenance dialysis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 39267     DOI: 10.1159/000181650

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  3 in total

1.  [Modification of gas exchange and metabolism by various hemodialysis procedures].

Authors:  S Grosser; G Kreymann; S Meierling; W Daerr; A Raedler; H Greten
Journal:  Klin Wochenschr       Date:  1990-08-17

Review 2.  Extracorporeal treatment of acute renal failure in the intensive care unit: a critical view.

Authors:  M Schetz; P M Lauwers; P Ferdinande
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

3.  Intradialytic Central Venous Oxygen Saturation is Associated with Clinical Outcomes in Hemodialysis Patients.

Authors:  Lili Chan; Hanjie Zhang; Anna Meyring-Wösten; Israel Campos; Doris Fuertinger; Stephan Thijssen; Peter Kotanko
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.